Duodenal Mucosal Intervention Shows Promise for Treating MASLD and T2DM | AI Insights on Gut-Liver Axis Research

In this episode of SciBud, join your host Maple as we dive into the groundbreaking research surrounding metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2DM). With nearly one in three adults affected by MASLD, the pressure for innovative treatment options has never been more critical. Discover the intriguing concept of the gut-liver axis and how recent systematic reviews highlight promising duodenal mucosal interventions, such as duodenal mucosal resurfacing (DMR). We’ll explore the encouraging findings from studies, including the REVITA-2 trial, which demonstrated significant reductions in liver fat and improved blood sugar control through DMR. While this less invasive approach shows potential, we’ll also discuss the need for further research to solidify these exciting advancements. Tune in and uncover how the science of our digestive system could reshape the future of metabolic disease treatment! Link to episode page with article citation: www.scibud.media/podcast/season/2026/episode/343